LH
Labcorp Holdings, Inc.
NYSE · Healthcare · Medical - Equipment & Services · US
$368.16
+2.20%Next report
Analyst consensus
- Next report date
- Feb 16, 2027
- EPS estimate
- $4.47
- Revenue estimate
- $3.7B
Latest reported
- Last report date
- Oct 28, 2026
- EPS actual
- $4.78
- EPS estimate
- $4.64
- Revenue actual
- $3.8B
- Revenue estimate
- $3.8B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- +3.6%
- Revenue beats (12Q)
- 5
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $371
- PT range
- $309 – $420
- Analysts
- 7
5 Buy2 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 28, 2026 | $4.64 | $4.78 | Beat 3.02% | $3.8B |
| Jul 30, 2026 | $4.78 | $4.99 | Beat 4.39% | $3.7B |
| Apr 30, 2026 | $4.09 | $4.25 | Beat 3.91% | $3.5B |
| Feb 17, 2026 | $3.95 | $4.07 | Beat 3.04% | $3.5B |
| Oct 28, 2025 | $4.13 | $4.18 | Beat 1.21% | $3.6B |
| Jul 24, 2025 | $4.17 | $4.35 | Beat 4.32% | $3.5B |
| Feb 6, 2025 | $3.39 | $3.45 | Beat 1.77% | $3.3B |
| Oct 24, 2024 | $3.47 | $3.50 | Beat 0.86% | $3.3B |
| Aug 1, 2024 | $3.78 | $3.94 | Beat 4.23% | $3.2B |
| Apr 25, 2024 | $3.48 | $3.68 | Beat 5.75% | $3.2B |
| Feb 15, 2024 | $3.29 | $3.30 | Beat 0.30% | $3.0B |
| Oct 26, 2023 | $3.37 | $3.38 | Beat 0.30% | $3.1B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 16, 2027